Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 6:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1561–1581 of 1,581 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Diabetes Mellitus, Sudden-Onset Clear all

Conditions: Type 1 Diabetes Mellitus
Interventions: Website; Behavioral
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 1 Day to 6 Years
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Diabetes Mellitus, Diabetic Nephropathies
Interventions: Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion, Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions; Drug
Lead sponsor: LaTonya J. Hickson; Other
Eligibility: 30 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Sleep Apnea, Obstructive, Type 1 Diabetes (T1D)
Interventions: Continuous positive airway pressure (CPAP); Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 50 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type 1 Diabetes
Interventions: Portal Insulin U-500, Humulin R U-500, Lyumjev U-100 Insulin; Drug
Lead sponsor: Portal Diabetes, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Breaking Down Barriers; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus, Type 1
Interventions: Observational; Other
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 7 Years to 16 Years
Enrollment: 221 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 5
States / cities: Palo Alto, California • New Haven, Connecticut • Jacksonville, Florida + 2 more

Conditions: Type 1 Diabetes Mellitus
Interventions: Promoting Resilience in Stress Management (PRISM); Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: Houston, Texas • Seattle, Washington

Conditions: Healthy Volunteers, Diabetes Mellitus, Type 1
Interventions: LY2605541, Insulin glargine; Drug · Other
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: San Diego, California

Conditions: Newly Diagnosed With Type 1 Diabetes
Interventions: Zenapax; Drug
Lead sponsor: Indiana University; Other
Eligibility: 2 Years to 40 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2007
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Type 1 Diabetes
Interventions: Terbutaline; Drug
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 12 Years to 18 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 6
States / cities: Stanford, California • New Haven, Connecticut • Jacksonville, Florida + 3 more

Conditions: Type 1 Diabetes Mellitus
Interventions: Positive Affect, Education; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 13 Years to 17 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Type 1 Diabetes
Interventions: Web-based Simulation Tool; Other
Lead sponsor: University of Virginia; Other
Eligibility: 21 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Polyneuropathy
Interventions: SB-509, Saline; Drug · Other
Lead sponsor: Sangamo Therapeutics; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 31
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 28 more

Conditions: Diabetes Mellitus, Type 1
Interventions: Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 352 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 46
States / cities: Little Rock, Arkansas • Concord, California • La Jolla, California + 43 more

Conditions: Type 1 Diabetes
Interventions: Stem Cell Educator therapy; Combination Product
Lead sponsor: Throne Biotechnologies Inc.; Industry
Eligibility: 10 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Paramus, New Jersey

Conditions: Type 1 Diabetes
Interventions: Transition Social Behavioral Intervention, Diabetes Transition Clinic; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 16 Years to 29 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Type 1 Diabetes Mellitus
Interventions: Continuous Glucose Sensor, Standard Care, CGS + Behavior Therapy; Device · Other · Behavioral
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 11 Years to 16 Years
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Diabetes Mellitus, Type 1
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 10 Years to 37 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Type 1 Diabetes (T1D)
Interventions: Sleep stability intervention; Behavioral
Lead sponsor: University of Illinois at Chicago; Other
Eligibility: 18 Years to 50 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type 1 Diabetes
Interventions: Bi-hormonal Bionic Pancreas, Usual Care; Device · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 12 Years to 20 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes
Interventions: Insulin Pump; Device
Lead sponsor: Medtronic MiniMed, Inc.; Industry
Eligibility: 2 Years to 13 Years
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 10
States / cities: Escondido, California • Palo Alto, California • Torrance, California + 7 more

Search by objective public record fields.

A Crowdsourced Social Media Portal for Parents of Very Young Children With Type 1 Diabetes

Stem Cell Therapy for Chronic Kidney Disease

Type 1 Diabetes and Obstructive Sleep Apnea

A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500

Breaking Down Barriers to Diabetes Self-Care

Type 1 Diabetes and the Brain in Children

PRISM for Adolescents With Type 1 Diabetes

A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

Prevention of Diabetes Progression Trial (PDPT)

A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes

Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D

Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes Mellitus

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)

Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes

Transition of Adolescents and Young Adults With Diabetes From Pediatric to Adult Care

Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control

AbATE Follow-Up Study

Circadian Mechanisms, Glucose, and CV Risks in T1D

The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes